EVERSANA Ontario Canada

As seen in: Wiley Online Library

Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with EVERSANA Ontario

Contact EVERSANA Ontario, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.

Claim your profile

Articles

Indirect treatment comparisons of the gene therapy etranacogene dezaparvovec versus extended half‐life factor IX therapies for severe or moderately severe haemophilia B

Oct 30, 2023 |

By Robert Klamroth, Ashley J. Bonner, Keith Gomez, EVERSANA Ontario Canada

| Wiley Online Library

1 INTRODUCTION The goal of haemophilia B therapy is to prevent and manage bleeding episodes.

Open in Who Shared

See all 1 articles

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.

Claim your profile

Get in touch with EVERSANA Ontario

Contact EVERSANA Ontario, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

For PR Teams

Overview

Use Cases

Capabilities

Industries

Introducing Curation Engine

Resources

Library

Commmunity

Customers

Company

EVERSANA Ontario Canada

Get in touch with EVERSANA Ontario

Actions

Is this you?

Articles

Indirect treatment comparisons of the gene therapy etranacogene dezaparvovec versus extended half‐life factor IX therapies for severe or moderately severe haemophilia B

Actions

Is this you?

Get in touch with EVERSANA Ontario